CELLCURA
LIVE

Serial Number

99302316

Owner

Cellcura Sciences, Inc.

Attorney

Cy Bates

Filing Date

Jul 25, 2025

Add to watchlist:

No watchlists yet
View on USPTO

CELLCURA Trademark

Serial Number: 99302316

CELLCURA is a trademark filed by Cellcura Sciences, Inc. on July 25, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Cellcura Sciences, Inc. (3 trademarks)

3400 W Mayflower Ave. Suite 122
Lehi, UT 84043

Entity Type: 03

Trademark Details

Filing Date

July 25, 2025

Registration Date

Not Registered

Published for Opposition

February 24, 2026

Goods & Services

Medical cleansers for skin and wounds; Liquid bandages for skin wounds; Pharmaceutical preparations for skin wounds; Bandages for skin wounds; Pharmaceutical preparations for wounds; Biological preparations for the treatment of musculoskeletal and orthopedic conditions including osteoarthritis, tendon and ligament injuries, fractures and non-unions, bulging or herniated discs, degenerative disc disease, carpal tunnel syndrome, cartilage injuries, muscle injuries, temporomandibular joint (TMJ) disorder, piriformis syndrome, sciatica, sacroiliac (SI) joint dysfunction, and osteonecrosis; Biological preparations for the treatment of autoimmune and inflammatory conditions including multiple sclerosis (MS), Crohn’s disease, and rheumatoid arthritis; Biological preparations for the treatment of neurological conditions including stroke, dementia, Parkinson’s disease, Huntington’s disease, spinal cord injury, post-concussion syndrome, and autism spectrum disorder; Biological preparations for the treatment of cardiovascular diseases including heart failure, peripheral artery disease, ischemic heart disease, and general cardiovascular disease; Biological preparations for the treatment of metabolic diseases including Type 1 and Type 2 diabetes, and obesity; Biological preparations for the treatment of hematological and immune diseases including, leukemia, lymphoma, myeloma, myelodysplastic syndrome, and myeloproliferative disorders; Biological preparations for the treatment of ophthalmologic conditions including macular degeneration, retinal detachment, and macular hole; Biological preparations for the treatment of liver and gastrointestinal diseases including chronic liver diseases, cirrhosis, liver failure, and Inflammatory bowel disease; Biological preparations for the treatment of chronic pain and degenerative conditions including fibromyalgia, chronic joint pain, and chronic wounds or non-healing ulcers

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 24, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 24, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 18, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 2, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 20, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 20, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 20, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 12, 2025 GNRN
NON-FINAL ACTION E-MAILED
Dec 12, 2025 GNRT
NON-FINAL ACTION WRITTEN
Dec 12, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 11, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 5, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 5, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jul 25, 2025 MAFR
NEW APPLICATION ENTERED
Jul 25, 2025 NWAP